本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CRISPR Therapeutics AG

55.72
-1.0400-1.83%
盤後55.50-0.2200-0.39%19:59 EDT
成交量:171.36萬
成交額:9,523.88萬
市值:53.48億
市盈率:-8.61
高:57.24
開:56.84
低:54.57
收:56.76
52周最高:78.48
52周最低:33.03
股本:9,598.53萬
流通股本:9,053.30萬
量比:1.08
換手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-6.4700
每股收益(LYR):-6.4700
淨資產收益率:-30.18%
總資產收益率:-15.76%
市淨率:2.78
市盈率(LYR):-8.61

資料載入中...

2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/20

重要事件披露

8-K - Current report
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/14

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report
2021/09/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/29

重要事件披露

8-K - Current report
2021/07/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/06/11

重要事件披露

8-K - Current report
2021/06/02

重要事件披露

8-K - Current report